Bressler, J
Yu, B
Mosley, T H
Knopman, D S
Gottesman, R F
Alonso, A
Sharrett, A R
Wruck, L M
Boerwinkle, E
Article History
Received: 5 August 2016
Revised: 5 April 2017
Accepted: 20 April 2017
First Online: 18 July 2017
Competing interests
: Dr Knopman served as Deputy Editor for <i>Neurology</i> until October 2015 and received compensation from the American Academy of Neurology. He serves on a Data Safety Monitoring Board for Lundbeck Pharmaceuticals and for the DIAN study, and is an investigator in clinical trials sponsored by TauRX Pharmaceuticals, Lilly Pharmaceuticals and the Alzheimer’s Disease Cooperative Study. The remaining authors declare no conflict of interest.